Leading the way to safer medication
 Crosscheck  Recommender

ATC Group: A10AB05 Insulin aspart

Anatomical Therapeutic Chemical Classification System

Hierarchical Position

Level
Code
Title
1
A
Alimentary tract and metabolism
2
A10
Drugs used in diabetes
3
A10A
Insulins and analogues
4
A10AB
Insulins and analogues for injection, fast-acting
5
A10AB05
Insulin aspart

Active Ingredients

Chemical substance
Description
Insulin aspart

The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. Insulin aspart produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. Insulin aspart has a shorter duration of action compared to soluble human insulin after subcutaneous injection.

Monographs

Monograph
Type
Country
NOVORAPID Solution for injection in vial / Cartridge / Pre-filled pen
MPI, EU: SmPC